(CRC) California Resources - Overview
Stock: Crude Oil, Natural Gas, Carbon Capture, Power Generation
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.45% |
| Yield on Cost 5y | 7.05% |
| Yield CAGR 5y | 25.54% |
| Payout Consistency | 100.0% |
| Payout Ratio | 35.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.1% |
| Relative Tail Risk | -5.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.54 |
| Alpha | 0.57 |
| Character TTM | |
|---|---|
| Beta | 1.255 |
| Beta Downside | 1.909 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.75% |
| CAGR/Max DD | 0.28 |
Description: CRC California Resources January 10, 2026
California Resources Corp (NYSE: CRC) is an independent U.S. energy and carbon-management firm that operates two primary segments: Oil & Natural Gas and Carbon Management. The company explores, develops, and produces crude oil, condensate, natural-gas liquids and dry gas for California refiners and other buyers, while its Carbon TerraVault business designs, builds, and operates CO₂ capture, transport and storage infrastructure. CRC also runs several power-generation assets, including small gas-fired plants that supply electricity to its upstream operations. Incorporated in 2014 and headquartered in Long Beach, California, CRC is classified under the GICS sub-industry “Oil & Gas Exploration & Production.”
Key quantitative points (as of the latest 2023 filings) include: ≈ 30 MMboe of proved reserves, a 2023 average production of ~ 35 MMboe ÷ year, and a net debt of roughly $1.2 billion, giving a debt-to-EBITDA ratio near 2.5×. The firm’s revenue is highly sensitive to West Texas Intermediate (WTI) crude prices and to California’s Low-Carbon Fuel Standard, which creates a premium for low-carbon oil and can offset carbon-management costs. Additionally, CRC’s carbon-capture projects are positioned to benefit from the U.S. 45Q tax credit, which currently offers up to $85 per tonne of CO₂ sequestered.
For a deeper dive into CRC’s valuation metrics and scenario analysis, ValueRay’s analyst notes provide a concise, data-driven overview.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 384.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.02 > 1.0 |
| NWC/Revenue: -2.97% < 20% (prev -0.95%; Δ -2.03% < -1%) |
| CFO/TA 0.12 > 3% & CFO 835.0m > Net Income 384.0m |
| Net Debt (904.0m) to EBITDA (1.26b): 0.71 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.4m) vs 12m ago -7.46% < -2% |
| Gross Margin: 37.89% > 18% (prev 0.43%; Δ 3746 % > 0.5%) |
| Asset Turnover: 50.88% > 50% (prev 37.01%; Δ 13.87% > 0%) |
| Interest Coverage Ratio: 5.95 > 6 (EBITDA TTM 1.26b / Interest Expense TTM 105.0m) |
Altman Z'' 2.07
| A: -0.02 (Total Current Assets 812.0m - Total Current Liabilities 917.0m) / Total Assets 6.75b |
| B: 0.29 (Retained Earnings 1.93b / Total Assets 6.75b) |
| C: 0.09 (EBIT TTM 625.0m / Avg Total Assets 6.94b) |
| D: 0.60 (Book Value of Equity 2.00b / Total Liabilities 3.31b) |
| Altman-Z'' Score: 2.07 = BBB |
Beneish M -2.90
| DSRI: 0.77 (Receivables 403.0m/393.0m, Revenue 3.53b/2.64b) |
| GMI: 1.13 (GM 37.89% / 42.91%) |
| AQI: 1.04 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 1.34 (Revenue 3.53b / 2.64b) |
| TATA: -0.07 (NI 384.0m - CFO 835.0m) / TA 6.75b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of CRC shares?
Over the past week, the price has changed by +3.59%, over one month by +19.44%, over three months by +21.17% and over the past year by +19.68%.
Is CRC a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.6 | 14.8% |
| Analysts Target Price | 63.6 | 14.8% |
| ValueRay Target Price | 62.7 | 13.2% |
CRC Fundamental Data Overview February 03, 2026
P/E Forward = 57.4713
P/S = 1.3632
P/B = 1.3582
P/EG = 0.5615
Revenue TTM = 3.53b USD
EBIT TTM = 625.0m USD
EBITDA TTM = 1.26b USD
Long Term Debt = 889.0m USD (from longTermDebt, last quarter)
Short Term Debt = 144.0m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 904.0m USD (from netDebt column, last quarter)
Enterprise Value = 5.68b USD (4.78b + Debt 1.10b - CCE 196.0m)
Interest Coverage Ratio = 5.95 (Ebit TTM 625.0m / Interest Expense TTM 105.0m)
EV/FCF = 10.43x (Enterprise Value 5.68b / FCF TTM 545.0m)
FCF Yield = 9.59% (FCF TTM 545.0m / Enterprise Value 5.68b)
FCF Margin = 15.43% (FCF TTM 545.0m / Revenue TTM 3.53b)
Net Margin = 10.88% (Net Income TTM 384.0m / Revenue TTM 3.53b)
Gross Margin = 37.89% ((Revenue TTM 3.53b - Cost of Revenue TTM 2.19b) / Revenue TTM)
Gross Margin QoQ = 38.38% (prev 37.03%)
Tobins Q-Ratio = 0.84 (Enterprise Value 5.68b / Total Assets 6.75b)
Interest Expense / Debt = 2.27% (Interest Expense 25.0m / Debt 1.10b)
Taxrate = 14.67% (11.0m / 75.0m)
NOPAT = 533.3m (EBIT 625.0m * (1 - 14.67%))
Current Ratio = 0.89 (Total Current Assets 812.0m / Total Current Liabilities 917.0m)
Debt / Equity = 0.32 (Debt 1.10b / totalStockholderEquity, last quarter 3.44b)
Debt / EBITDA = 0.71 (Net Debt 904.0m / EBITDA 1.26b)
Debt / FCF = 1.66 (Net Debt 904.0m / FCF TTM 545.0m)
Total Stockholder Equity = 3.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.53% (Net Income 384.0m / Total Assets 6.75b)
RoE = 11.05% (Net Income TTM 384.0m / Total Stockholder Equity 3.48b)
RoCE = 14.32% (EBIT 625.0m / Capital Employed (Equity 3.48b + L.T.Debt 889.0m))
RoIC = 11.81% (NOPAT 533.3m / Invested Capital 4.52b)
WACC = 8.93% (E(4.78b)/V(5.88b) * Re(10.54%) + D(1.10b)/V(5.88b) * Rd(2.27%) * (1-Tc(0.15)))
Discount Rate = 10.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 9.22%
[DCF Debug] Terminal Value 78.30% ; FCFF base≈442.6m ; Y1≈546.0m ; Y5≈929.8m
Fair Price DCF = 137.8 (EV 13.21b - Net Debt 904.0m = Equity 12.31b / Shares 89.3m; r=8.93% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -25.43 | EPS CAGR: -47.58% | SUE: -1.69 | # QB: 0
Revenue Correlation: 12.28 | Revenue CAGR: 5.95% | SUE: -0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.29 | Chg30d=-0.106 | Revisions Net=-2 | Analysts=8
EPS next Year (2026-12-31): EPS=1.78 | Chg30d=-0.591 | Revisions Net=-4 | Growth EPS=-57.5% | Growth Revenue=-1.0%